Citation Impact
Citing Papers
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
2016
A Chemically Defined Trifunctional Antibody–Cytokine–Drug Conjugate with Potent Antitumor Activity
2014
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
2013
Bispecific antibodies for cancer therapy
2009
Evolution of the Cancer Stem Cell Model
2014 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
2016 StandoutNobel
Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice
2016
Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
2013
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Top 10 Challenges in Cancer Immunotherapy
2020
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Toxicity management for patients receiving novel T-cell engaging therapies
2013
Lipid nanoparticles for mRNA delivery
2021 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Tertiary lymphoid structures in cancer and beyond
2014
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Transiently redirected T cells for adoptive transfer
2010
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Engineering lymphocyte subsets: tools, trials and tribulations
2009
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Therapeutic antibodies for autoimmunity and inflammation
2010
Antibody therapy of cancer
2012 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Introduction to current and future protein therapeutics: A protein engineering perspective
2011
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
2015
Emerging cell and cytokine targets in rheumatoid arthritis
2013
Bispecific antibodies for cancer therapy: A review
2017
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
2014
Multispecific drugs herald a new era of biopharmaceutical innovation
2020 Nature
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Bispecific antibodies: a mechanistic review of the pipeline
2019
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
2014
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Engineered Proteins Pull Double Duty
2010
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
2011
Acute Myeloid Leukemia
2015 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Alternative molecular formats and therapeutic applications for bispecific antibodies
2015
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Advances in targeted therapeutic agents
2010
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
Cytokine Storm
2020 Standout
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
2011
Chimeric Antigen Receptor Therapy
2018 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
Synthesis of Bispecific Antibodies using Genetically Encoded Unnatural Amino Acids
2012
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds
2008
Modern Technologies for Creating Synthetic Antibodies for Clinical Application
2009
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Works of Margit Schmidt being referenced
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
2008 Science